1887

Abstract

EBNA-1 is the only viral protein consistently expressed in all cells latently infected by Epstein–Barr virus (EBV). There is a high frequency of sequence variation within functionally important domains of EBNA-1, with five subtypes identified. Individuals may be infected with multiple EBV strains (classified according to EBNA-1 subtype), but Burkitt’s lymphoma (BL) tumours carry a single subtype and exhibit some subtype preference. Subtype variation has also been related to geographical location. In the present study EBNA-1 polymorphisms were examined in a series of haematological malignancies from two distinct geographical regions, Brazil and the United Kingdom. Nucleotide sequence analysis of the carboxy-terminal region of EBNA-1 in 34 cases revealed six distinct sequences, some of which are novel. A new subtype, named V-Ala, was identified. EBNA-1 subtype in tumours differed markedly according to geographical location. In contrast to previous studies, we found evidence of EBNA-1 sequence variation within individual BL tumour samples.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-10-2741
1999-10-01
2021-10-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/10/0802741a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-10-2741&mimeType=html&fmt=ahah

References

  1. Ambinder R. F., Mullen M., Chang Y. N., Hayward G. S., Hayward S. D. 1991; Functional domains of Epstein–Barr virus nuclear antigen EBNA-1. Journal of Virology 65:1466–1478
    [Google Scholar]
  2. Armstrong A. A., Weiss L. M., Gallagher A., Jones D. B., Krajewski A. S., Angus B., Brown G., Jack A. S., Wilkins B. S., Onions D. E., Jarrett R. F. 1992; Criteria for the definition of Epstein–Barr virus association in Hodgkin’s disease. Leukemia 6:869–874
    [Google Scholar]
  3. Bhatia K., Raj A., Gutiérrez M. I., Judde J. G., Spangler G., Venkatesh H., Magrath I. T. 1996; Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt’s lymphomas. Oncogene 13:177–181
    [Google Scholar]
  4. Biesinger B., Muller-Fleckenstein I., Simmer B., Lang G., Wittmann S., Platzer E., Desrosiers R. C., Fleckenstein B. 1992; Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proceedings of the National Academy of Sciences, USA 89:3116–3119
    [Google Scholar]
  5. Bochkarev A., Barwell J. A., Pfuetzner R. A., Bochkareva E., Frappier L., Edwards A. M. 1996; Crystal structure of the DNA-binding domain of the Epstein–Barr virus origin-binding protein, EBNA1, bound to DNA. Cell 84:791–800
    [Google Scholar]
  6. Chen Y. Y., Chang K. L., Chen W. G., Shibata D., Hayashi K., Weiss L. M. 1998; Epstein–Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma. Laboratory Investigation 78:877–882
    [Google Scholar]
  7. Chen M. R., Tsai C. H., Wu F. F., Kan S. H., Yang C. S., Chen J. Y. 1999; The major immunogenic epitopes of Epstein–Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines. Journal of General Virology 80:447–455
    [Google Scholar]
  8. Epstein M. A., Achong B. G., Barr Y. M. 1964; Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet i:702–703
    [Google Scholar]
  9. Felsenstein J. 1981; Evolutionary trees from DNA sequences – a maximum likelihood approach. Journal of Molecular Evolution 17:368–376
    [Google Scholar]
  10. Gutiérrez M. I., Raj A., Spangler G., Sharma A., Hussain A., Judde J. G., Tsao S. W., Yuen P. W., Joab I., Magrath I. T., Bhatia K. 1997a; Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein–Barr virus in normal and tumour cells. Journal of General Virology 78:1663–1670
    [Google Scholar]
  11. Gutiérrez M. I., Spangler G., Magrath I. T., Bhatia K. 1997 b The wild type sequence of EBNA-1 is incompatible with EBV associated lymphomas: evidence that tumor associated EBNA-1 mutations arise in vivo. [Meeting abstract.]. Blood 90:Suppl. 101081
    [Google Scholar]
  12. Gutiérrez M. I., Spangler G., Kingma D., Raffeld M., Guerrero I., Misad O., Jaffe E. S., Magrath I. T., Bhatia K. 1998; Epstein–Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene. Blood 92:600–606
    [Google Scholar]
  13. Habeshaw G., Yao Q. Y., Bell A. I., Morton D., Rickinson A. B. 1999; Epstein–Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt’s lymphoma reflect virus strains prevalent in different geographic areas. Journal of Virology 73:965–975
    [Google Scholar]
  14. Hamilton-Dutoit S. J., Raphael M., Audouin J., Diebold J., Lisse I., Pedersen C., Oksenhendler E., Marelle L., Pallesen G. 1993; In situ demonstration of Epstein–Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 82:619–624
    [Google Scholar]
  15. Kieff E. 1996; Epstein–Barr virus and its replication. In Fields Virology pp 2343–2396 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
  16. Li S. N., Chang Y. S., Liu S. T. 1996; Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein–Barr virus. Oncogene 12:2129–2135
    [Google Scholar]
  17. Magrath I. 1990; The pathogenesis of Burkitt’s lymphoma. Advances in Cancer Research 55:133–270
    [Google Scholar]
  18. Rowe M., Lear A. L., Croom-Carter D., Davies A. H., Rickinson A. B. 1992; Three pathways of Epstein–Barr virus gene activation from EBNA1-positive latency in B lymphocytes. Journal of Virology 66:122–131
    [Google Scholar]
  19. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
  20. Shimizu H., Burns J. C. 1995; Extraction of nucleic acids: sample preparation from paraffin-embedded tissues. In PCR Strategies pp 32–38 Edited by Innis M. A., Gelfand D. H., Sninsky J. J. London: Academic Press;
    [Google Scholar]
  21. Snudden D. K., Smith P. R., Lai D., Ng M. H., Griffin B. E. 1995; Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene 10:1545–1552
    [Google Scholar]
  22. Sugden B., Warren N. 1989; A promoter of Epstein–Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection. Journal of Virology 63:2644–2649
    [Google Scholar]
  23. Trainor C. D., Wongstaal F., Reitz M. S. Jr 1982; Comparative restriction endonuclease maps of proviral DNA of the primate type C simian sarcoma-associated virus and gibbon ape leukemia virus group. Journal of Virology 41:298–308
    [Google Scholar]
  24. Weiss L. M., Strickler J. G., Warnke R. A., Purtilo D. T., Sklar J. 1987; Epstein–Barr viral DNA in tissues of Hodgkin’s disease. American Journal of Pathology 129:86–91
    [Google Scholar]
  25. Wrightham M. N., Stewart J. P., Janjua N. J., De V Pepper S., Sample C., Rooney C. M., Arrand J. R. 1995; . Antigenic and sequence variation in the C-terminal unique domain of the Epstein–Barr virus nuclear antigen EBNA-1. Virology 208:521–530
    [Google Scholar]
  26. Yates J. L. 1996; Epstein–Barr virus DNA replication. In DNA Replication in Eukaryotic Cells pp 751–773 Edited by DePamphilis M. L. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  27. Zong J. C., Metroka C., Reitz M. S., Nicholas J., Hayward G. S. 1997; Strain variability among Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genomes: evidence that a large cohort of United States AIDS patients may have been infected by a single common isolate. Journal of Virology 71:2505–2511
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-10-2741
Loading
/content/journal/jgv/10.1099/0022-1317-80-10-2741
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error